AbbVie Inc (ABBV)
194.29
-1.16
(-0.59%)
USD |
NYSE |
Oct 04, 16:00
193.90
-0.39
(-0.20%)
Pre-Market: 20:00
AbbVie Shareholders Equity (Annual): 10.36B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.36B |
| December 31, 2022 | 17.25B |
| December 31, 2021 | 15.41B |
| December 31, 2020 | 13.08B |
| December 31, 2019 | -8.172B |
| December 31, 2018 | -8.446B |
| December 31, 2017 | 5.097B |
| Date | Value |
|---|---|
| December 31, 2016 | 4.636B |
| December 31, 2015 | 3.945B |
| December 31, 2014 | 1.742B |
| December 31, 2013 | 4.492B |
| December 31, 2012 | 3.363B |
| December 31, 2011 | 11.93B |
| December 31, 2010 | 15.70B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-8.172B
Minimum
2019
17.25B
Maximum
2022
9.585B
Average
13.08B
Median
2020
Shareholders Equity (Annual) Benchmarks
| Amgen Inc | 6.232B |
| Johnson & Johnson | 68.77B |
| Eli Lilly and Co | 10.77B |
| Merck & Co Inc | 37.58B |
| Pfizer Inc | 89.01B |